Novel longitudinal Multiple Overall Toxicity (MOTox) score to quantify adverse events experienced by patients during chemotherapy treatment: a retrospective analysis of the MRC BO06 trial in osteosarcoma.
Marta SpreaficoFrancesca IevaFrancesca ArlatiFederico CapelloFederico FatoneFilippo FedeliGianmarco GenaltiJakob AnningaHans GelderblomMarta FioccoPublished in: BMJ open (2021)
ISRCTN86294690; Post-results.